Cargando…

A MEK-independent role for CRAF in mitosis and tumor progression

Detalles Bibliográficos
Autores principales:	Mielgo, Ainhoa, Seguin, Laetitia, Huang, Miller, Camargo, Maria Fernanda, Anand, Sudarshan, Franovic, Aleksandra, Weis, Sara M., Advani, Sunil J., Murphy, Eric A., Cheresh, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233644/ https://www.ncbi.nlm.nih.gov/pubmed/22081024 http://dx.doi.org/10.1038/nm.2464

Ejemplares similares

Kinase-independent role for CRAF-driving tumour radioresistance via CHK2
por: Advani, Sunil J., et al.
Publicado: (2015)

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2
por: Wang, Penglei, et al.
Publicado: (2023)

CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition
por: Noeparast, Amir, et al.
Publicado: (2019)

Targeting the Achilles’ heel of drug-resistant cancer stem cells
por: Seguin, Laetitia, et al.
Publicado: (2014)

Selective CRAF Inhibition Elicits Transactivation
por: Morgan, Charles W., et al.
Publicado: (2021)

MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment
por: Wilson, RaeAnna, et al.
Publicado: (2016)

CRAF R391W is a melanoma driver oncogene
por: Atefi, Mohammad, et al.
Publicado: (2016)

Three distinct regions of cRaf kinase domain interact with membrane
por: Prakash, Priyanka, et al.
Publicado: (2019)

Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
por: Chatelle, Claire V., et al.
Publicado: (2016)

EGFR/MEK/ERK/CDK5-dependent integrin-independent FAK phosphorylated on serine 732 contributes to microtubule depolymerization and mitosis in tumor cells
por: Rea, K, et al.
Publicado: (2013)

Impaired neuronal maturation of hippocampal neural progenitor cells in mice lacking CRAF
por: Pfeiffer, Verena, et al.
Publicado: (2018)

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
por: Heidorn, Sonja J., et al.
Publicado: (2010)

Oncogenic RAS drives the CRAF‐dependent extracellular vesicle uptake mechanism coupled with metastasis
por: Choi, Dongsic, et al.
Publicado: (2021)

APC(cdh1) Mediates Degradation of the Oncogenic Rho-GEF Ect2 after Mitosis
por: Liot, Caroline, et al.
Publicado: (2011)

Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma
por: Luan, Zhou, et al.
Publicado: (2014)

Registered report: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF
por: Bhargava, Ajay, et al.
Publicado: (2016)

X-linked Inhibitor of Apoptosis Protein negatively regulates neuronal differentiation through interaction with cRAF and Trk
por: Fadó, Rut, et al.
Publicado: (2013)

CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles
por: Jain, P, et al.
Publicado: (2017)

EGFR-dependent pancreatic carcinoma cell metastasis via Rap1 activation
por: Huang, Miller, et al.
Publicado: (2011)

A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway
por: Liu, Shufeng, et al.
Publicado: (2015)

A CRAF/glutathione-S-transferase P1 complex sustains autocrine growth of cancers with KRAS and BRAF mutations
por: Niitsu, Yoshiro, et al.
Publicado: (2020)

Implications of glutathione-S transferase P1 in MAPK signaling as a CRAF chaperone: In memory of Dr. Irving Listowsky
por: NIITSU, Yoshiro, et al.
Publicado: (2022)

EGFR-Mediated Carcinoma Cell Metastasis Mediated by Integrin αvβ5 Depends on Activation of c-Src and Cleavage of MUC1
por: Lau, Steven K. M., et al.
Publicado: (2012)

RAF1-activated MEK1 is found on the Golgi apparatus in late prophase and is required for Golgi complex fragmentation in mitosis
por: Colanzi, Antonino, et al.
Publicado: (2003)

Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors
por: Jaiswal, Bijay S., et al.
Publicado: (2009)

The AMPK inhibitor overcomes the paradoxical effect of RAF inhibitors through blocking phospho–Ser-621 in the C terminus of CRAF
por: Yuan, Jimin, et al.
Publicado: (2018)

A Specific Activation of the Mitogen-Activated Protein Kinase Kinase 1 (Mek1) Is Required for Golgi Fragmentation during Mitosis
por: Colanzi, Antonino, et al.
Publicado: (2000)

Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling
por: Wu, Jianguo, et al.
Publicado: (2016)

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF)
por: Sun, Yihong, et al.
Publicado: (2019)

Targeting the Surface of the Protein 14‐3‐3 by Ultrasmall (1.5 nm) Gold Nanoparticles Carrying the Specific Peptide CRaf
por: Ruks, Tatjana, et al.
Publicado: (2021)

Sex disparities in non-small cell lung cancer: mechanistic insights from a cRaf transgenic disease model
por: Zhong, Shen, et al.
Publicado: (2023)

Re-thinking the preclinical development of GBM therapeutics
por: Cosset, Érika, et al.
Publicado: (2018)

MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK–ERK Signaling
por: Evans, Catherine, et al.
Publicado: (2013)

Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities
por: Freeman, Patrick, et al.
Publicado: (2020)

Committing to mitosis
por: Wells, William A.
Publicado: (2003)

The Cell in Mitosis
por: Lubs, Herbert A.
Publicado: (1964)

Histone Deacetylase Inhibitors Interrupt HSP90•RASGRP1 and HSP90•CRAF Interactions to Upregulate BIM and Circumvent Drug Resistance in Lymphoma Cells
por: Ding, Husheng, et al.
Publicado: (2016)

Impact of tumour associated macrophages in pancreatic cancer
por: Mielgo, Ainhoa, et al.
Publicado: (2013)

Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
por: Ireland, Lucy V., et al.
Publicado: (2018)

Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis
por: Weis, Sara, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_mop9a6jgnvcuaiv4t9836d26d4